Amgen Cancer Drug Fails in Phase 3 Study Thousand Oaks, Calif — Amgen, Cambridge, Mass-based Millennium: The Takeda Oncology Company, and Takeda Pharmaceutical Co, Osaka, Japan, announced the top-line results from the pivotal
Read More
Positive Early Results for Parkinson’s Treatment Michael J. Fox Harbor BioSciences, San Diego, which is investigating the use the company’s proprietary compound Triolex as a treatment for Parkinson’s disease (PD) with fund
Read MoreThreshold Pharmaceuticals announced agreement with the FDA on a special protocol assessment for planned Phase 3 TH-302 combination trial in advanced soft-tissue sarcoma.
Read MoreBiocare Medical and the Henry M Jackson Foundation for the Advancement of Military Medicine announce exclusive distribution agreement for a highly specific monoclonal antibody.
Read More
Multiplex Lyme, Syphilis, and ToRCH IgG The AtheNA Multi-Lyte® menu offered by Alere Inc, Waltham, Mass, includes three new infectious disease assays. Borrelia VlsE-1/ pepC10 is used as a first-tier test to detect qualitative levels of B. bu
Read More